NCT05055843Active, not recruiting
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Prostate Cancer Without an Endorectal Coil
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This clinical trial studies examines a 3D magnetic resonance imaging (MRI) compared to standard MRI imaging techniques in screening patients with prostate cancer. Diagnostic procedures, such as MRI, may help find and diagnose prostate cancer. Computer systems that allow doctors to create a 3-dimensional (3-D) picture of the tumor may help in planning.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 21 Jul 2021
- Start date
- 10 Aug 2021
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT05055843
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 10 Aug 2021 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any prior therapy for prostate cancer
Other illness
- A history of other active malignancy within the last 2 years
- Prostate cancer with significant sarcomatoid, spindle cell, or neuroendocrine small cell components
- Cardiac pacemaker
Other
- Low-risk adenocarcinoma of prostate
- Orthopedic hardware in the pelvis and spine
- Claustrophobia
Who the study is looking for
- Male, age \>= 18
- Untreated, biopsy-proven with intermediate and high-risk adenocarcinoma of the prostate
- Patient is being considered for curative-intent treatment with radical prostatectomy
- Patient has provided written informed consent for participation in this trial
- Patient should be eligible for scanning on a 3T magnet
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.